The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-β1 signaling

Carcinogenesis

Volumn 29, Issue 5, 2008, Pages 890-894

  Biasi, Fiorella ^a   Mascia, Cinzia ^a   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE; ARACHIDONIC ACID; CHOLESTEROL; CYTOKINE; DNA; INTERLEUKIN 1; INTERLEUKIN 6; LINOLEIC ACID; LIPID; OMEGA 6 FATTY ACID; OXYSTEROL; POLYUNSATURATED FATTY ACID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; DNA DAMAGE; FAT INTAKE; FATTY ACID OXIDATION; FIBROBLAST; GROWTH REGULATION; HUMAN; INHIBITION KINETICS; INTESTINE MUCOSA; LIPID DIET; LIPID OXIDATION; LIPID PEROXIDATION; MACROPHAGE; MALIGNANT TRANSFORMATION; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; CELL DIFFERENTIATION; CELL DIVISION; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DIETARY FATS; FATTY ACIDS, OMEGA-6; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIFE STYLE; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 47249131243     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn106     Document Type: Review

References (78)

1. Reddy,B.S. (2004) Omega-3 fatty acids in colorectal cancer prevention. Int. J. Cancer, 112, 1-7.
2. Leonardazzi,G. et al. (1997) The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J., 11, 851-857.
3. Leonarduzzi,G. et al. (2001) Up-regulation of the fibrogenic cytokine TGF-beta1 by oxysterols: A mechanistic link between cholesterol and atherosclerosis. FASEB J., 15, 1619-1621.
4. Biasi,F. et al. (2002) Associated changes of lipid peroxidation and transforming growth factor β1 levels in human colon cancer during tumour progression. Gut, 5, 361-367.
5. Olaru,A. et al. (2003) Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors. Lab. Invest., 83, 1867-1871.
6. Jung,B. et al. (2006) Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int. J. Cancer, 118, 2509-2513.
7. McNamara,D.J. (2000) Dietary cholesterol and atherosclerosis. Biochim. Biophys. Acta, 1529, 310-320.
8. Schroepfer,G.J. Jr (2000) Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol. Rev., 80, 361-554.
9. Renaud,S. et al. (2001) Coronary heart disease: Dietary links and pathogenesis. Public Health Nutr., 4, 459-474.
10. Mills,S.C. et al. (2005) The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin. Exp. Immunol., 142, 216-228.
11. Donaldson,M.S. (2004) Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr. J., 20, 3-19.
12. Chao,A. et al. (2005) Meat consumption and risk of colorectal cancer. JAMA, 293, 172-182.
13. Simopoulos,A.P. (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomed. Pharmacother., 60, 502-507.
14. Harbige,L.S. (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids, 38, 323-341.
15. Trebble,T.M. et al. (2004) Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin. Nutr., 23, 647-655.
16. Alzoghaibi,M.A. et al. (2004) Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am. J. Physiol. Gastrointest. Liver Physiol., 286, G528-G537.
17. Calder,P.C. (2005) Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans., 33, 423-427.
18. Pan,J. et al. (2002) Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions. Chem. Res. Toxicol., 15, 367-372.
19. Moonen,H.J. et al. (2004) Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells. Mol. Carcinog., 40, 180-188.
20. Poli,G. et al. (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life, 50, 315-321.
21. Poli,G. et al. (2008) 4-Hydroxynonenal: A membrane lipid oxidation product of medicinal interest. Med. Res. Rev., 28, 569-631.
22. Karten,B. et al. (1999) Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein. J. Lipid Res., 40, 1240-1253.
23. Spiteller,G. (2005) The relation of lipid peroxidation processes with atherogenesis: A new theory on atherogenesis. Mol. Nutr. Food Res. 49, 999-1013.
24. Huber,T. et al. (2002) Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway. Arterioscler. Thromb. Vasc. Biol., 22, 581-586.
25. Leonarduzzi,G. et al. (2002) Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J. Nutr. Biochem., 13, 700-710.
26. Leonarduzzi,G. et al. (2005) Oxidized products of cholesterol: toxic effect. In Preedy, V.R. and Watson,R.R. (eds.) Reviews in food and nutrition toxicity, CRC Press, Taylor & Francis Group, Boca Raton, FL, Vol. 3, pp. 129-164.
27. Rey,A.I. et al. (2001) Effect of dietary oils and alpha-tocopheryl acetate supplementation on lipid (TBARS) and cholesterol oxidation in cooked pork. J. Anim. Sci., 79, 1201-1208.
28. Chien,J.T. et al. (2004) Kinetic studies of cholesterol oxidation as inhibited by stearylamine during heating. J. Agric. Food. Chem. 52, 7132-7138.
29. Krut,L.H. et al. (1997) The effect of oxidizing cholesterol on gastrointestinal absorption, plasma clearance, tissue distribution, and processing by endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 778-785.
30. Tsianos,E.V. (2000) Risk of cancer in inflammatory bowel disease (IBD). Eur J. Intern. Med., 11, 75-78.
31. Kruidenier,L. et al. (2002) Review article: Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment. Pharmacol. Ther., 16, 1997-2015.
32. Itzkowitz,S.H. et al. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287 G7-G17.
33. O'Sullivan,A.J. et al. (2003) Toxicity of cholesterol oxidation products to Caco-2 and HepG2 cells: Modulatory effects of α- and β-tocopherol. J. Appl. Toxicol., 23, 191-197.
34. Whiting,C.V. et al. (2005) Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm. Bowel Dis., 11, 340-349.
35. James,M.J. et al. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr., 71, 343S-348S.
36. Ariel,A. et al. (2007) Resolvins and protectins in the termination program of acute inflammation. Trends Immunol., 28, 176-183.
37. Powell,D.W. et al. (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol., 277, C1-C19.
38. Amati,B. (2001) Integrating Myc and TGF-beta signalling in cell-cycle control. Nat. Cell Biol., 3, E112-E113.
39. Sánchez-Capelo,A. (2005) Dual role for TGF-β1 in apoptosis. Cytokine Growth Factor Rev., 16, 15-34.
40. Massaguè, J. et al. (2006) The logic of TGFbeta signaling. FEBS Lett., 580, 2811-2820.
41. Radtke,F. et al. (2006) From gut homeostasis to cancer. Curr Mol. Med., 6, 275-289.
42. Jürgensmeier,J.M. et al. (1994) Transforming growth factor beta-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res., 54, 393-398.
43. Panse,J. et al. (1997) Fibroblasts transformed by chemical carcinogens are sensitive to intercellular induction of apoptosis: implications for the control of oncogenesis. Carcinogenesis, 18 259-264.
44. Bauer,G. (2007) Low dose radiation and intercellular induction of apoptosis: Potential implications for the control of oncogenesis. Int. J. Radiat. Biol., 83, 873-888.
45. Poli,G. et al. (1997) Oxidative damage and fibrogenesis. Free Radic. Biol. Med., 22, 287-305.
46. Chiarpotto,E. et al. (1997) Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radic. Biol. Med., 22, 889-894.
47. Poli,G. (2000) Pathogenesis of liver fibrosis: Role of oxidative stress. Mol. Aspects Med., 21, 49-98.
48. Zamara,E. et al. (2004) 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol., 40, 60-68.
49. Parola,M. et al. (1996) Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. Biochem. Biophys. Res. Commun., 222 261-264.
50. Leonarduzzi,G. et al. (2000) Lipid oxidation products in cell signaling. Free Radic. Biol. Med., 28, 1370-1378.
51. Biasi,F. et al. (2006) c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic. Biol. Med., 41, 443-454.
52. Shoda,R. et al. (1996) Epidermologic analysis of Crohn disease in Japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am. J. Clin. Nutr., 63, 741-745.
53. Kuroki,F. et al. (1997) Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease. Dig. Dis. Sci., 42, 1137-1141.
54. MacLean,C.H. et al. (2005) Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am. J. Clin. Nutr., 82, 611-619.
55. Sottero,B. et al. (2005) Expression and synthesis of TGFbeta1 is induced in macrophages by 9-oxononanoyl cholesterol, a major cholesteryl ester oxidation product. Biofactors, 24, 209-216.
56. Liang,C.J. et al. (2008) 20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-beta. J. Lipid Res., 49, 66-73.
57. Wu,Z. et al. (2007) Involvement of prostaglandin E2 released from lepto-meningeal cells in increased expression of transforming growth factor-beta in glial cells and cortical neurons during systemic inflammation. J. Neurosci. Res., 85, 184-192.
58. Shim,Y.M. et al. (2006) Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodelling. J. Immunol., 177, 1918-1924.
59. Bossé,Y. et al. (2008) Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. Clin. Exp. Allergy, 38, 113-121.
60. Shacter,E. et al. (2002) Chronic inflammation and cancer. Oncology, 16, 217-226, 229, 230-232.
61. Coussens,L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
62. Martinez,G.R. et al. (2003) Oxidative and alkylating damage in DNA. Mutat. Res., 544, 115-127.
63. Pierre,F. et al. (2006) New marker of colon cancer risk associated with heme intake: 1,4-dihydroxy nonane mercapturic acid. Cancer Epidemiol. Biomarkers Prev., 15, 2274-2279.
64. Glei,M. et al. (2007) Comet fluorescence in situ hybridization analysis for oxidative stress-induced DNA damage in colon cancer relevant genes. Toxicol. Sci., 96, 279-284.
65. Markowitz,S.D. et al. (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev., 7, 93-102.
66. Massaguè,J. et al. (2000) TGFβ signaling in growth control, cancer, and heritable disorders. Cell, 103, 295-309.
67. de Caestecker,M.P. et al. (2000) Role of transforming growth factor-beta signaling in cancer. J. Natl Cancer Inst., 92, 1388-1402.
68. Elliott,R.L. et al. (2005) Role of transforming growth factor beta in human cancer. J. Clin. Oncol., 23, 2078-2093.
69. Wang,J. et al. (1995) Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270, 22044-22049.
70. Woodford-Richens,K. et al. (2000) Allelic loss of SMAD4 in polyps from juvenile poliposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Res., 60, 2477-2482.
71. Kim,B.G. et al. (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature, 441, 1015-1019.
72. Li,F. et al. (2005) TGF-beta signaling in colon cancer cells. World J. Surg., 29, 306-311.
73. Dianzani,M.U. (1993) Lipid peroxidation and cancer. Crit. Rev. Oncol. Hematol., 15, 125-147.
74. Bacman,D. et al. (2007) TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: A retrospective study. BMC Cancer, 10, 7-156.
75. Bhowmick,N.A. et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science, 6, 848-851.
76. Bhowmick,N.A. et al. (2004) Stromal fibroblasts in cancer initiation and progression. Nature, 18, 332-337.
77. Barcellos-Hoff,M.H. et al. (1996) Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol., 10 1077-1083.
78. Jakowlew,S.B. (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev., 25, 435-457.